LANCASTER, Pa. & BOSTON--(BUSINESS WIRE)--Skipta, the leading provider of online specialty and disease state medical communities for verified healthcare professionals, announced today that it has received Series A funding in the amount of $2.5 million from healthcare-focused private equity firm, Mansa Capital. As part of the transaction, Mansa Capital Partner, James Renna will join the Skipta Board of Directors.
The funding will be utilized to accelerate network development, increase community membership, and expand the company’s executive team. Skipta will continue to invest in enhancing its technology platform, deepening member engagement and diversifying its unique product portfolio.
Founded by Dr. Theodore Search, PharmD, Skipta launched its first community, Pharmacist Society, in 2009, and now manages a network of 28 niche online medical communities. Each is tailored per specialty or disease state, fostering vibrant clinical collaboration, information exchange and virtual interaction to support the professional, scientific, medical and economic development of healthcare professionals.
“We are excited to collaborate with Mansa Capital. They are an ideal partner to fuel Skipta’s mission to empower HCPs to be more effective, efficient and successful through shared values of integrity and collaboration, cementing our commitment to advancing healthcare services and technology,” commented Skipta Founder & CEO, Dr. Theodore Search.
Mansa Capital invests primarily in high-growth healthcare service and technology companies with successful management teams, sound business franchises and substantial potential. The healthcare private equity investment firm seeks to develop companies that deliver advances in cost-effective care, demonstrate potential for strong organic revenue growth and exhibit attractive margins as well as high returns on capital.
“Skipta exemplifies what we’re looking for in healthcare growth equity investments—ones that leverage leading edge technology to increase patient engagement and improve outcomes in the post-reform environment,” said Ruben J. King-Shaw Jr., Mansa Capital Managing Partner & CIO. “As part of Mansa Capital Fund I, LP, our investment in Skipta will see the company through key growth phases, which will be guided with our signature hands-on approach by James Renna, Mansa Capital Operating Partner and Head of the firm’s Operations and Advisory Group.”
Skipta is the leading provider of online specialty and disease state medical communities for verified healthcare professionals. Skipta’s growing closed loop network of 28 niche medical communities enables healthcare professionals to communicate, consult and exchange information within private and secure platforms per specialty or disease state. Skipta supports the medical advancement of its members by offering a range of collaborative peer based services that aid quality of care and contribute to improved patient outcomes. Skipta’s network provides trusted forums and a range of tools for the life sciences industry to engage with healthcare professionals. For more information, please visit www.skipta.com.
About Mansa Capital
Headquartered in Boston, MA, with local offices in New York City, Miami and Dallas, Mansa Capital is a private equity firm focused on the $2.5 trillion healthcare sector in the US including Puerto Rico and the US Virgin Islands. The firm uses its expertise in healthcare policy and economics to help management teams grow top line revenues and develop new products that build exceptional value. Mansa Capital’s principals bring to the firm extensive expertise in healthcare operations, marketing and finance including senior-level experience in healthcare compliance, regulation and reimbursement. The team has distinctive knowledge in the early identification of innovative business models that enable patients and providers to thrive in the post-healthcare reform environment. The firm also has special insights in the largely untapped Hispanic healthcare market. www.MansaCapital.com